List of insiders holdings for Agomab Therapeutics NV:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Knotnerus Tim Jasper Chief Executive Officer | 2026-03-18 16:01:46 | 2,093,698 34,394 | 2,128,092 | Form 3 |
| 2 | Epstein David R Director | 2026-03-18 16:01:48 | 1,026,809 0 | 1,026,809 | Form 3 |
| 3 | Wiesel Philippe Constantin Chief Medical Officer | 2026-03-18 16:01:30 | 627,775 0 | 627,775 | Form 3 |
| 4 | van der Horst Paul Henryk Chief Business Officer | 2026-03-18 16:01:37 | 612,556 0 | 612,556 | Form 3 |
| 5 | Borderias Andrea Saez Chief Development Officer | 2026-03-18 16:01:33 | 586,154 0 | 586,154 | Form 3 |
| 6 | Kemula Pierre Thadee Victor Chief Financial Officer | 2026-03-18 16:01:40 | 583,020 0 | 583,020 | Form 3 |
| 7 | Lefever Ellen General Counsel | 2026-03-18 16:01:31 | 457,304 0 | 457,304 | Form 3 |
| 8 | Jahreis Angelika Martha Director | 2026-03-18 16:01:39 | 154,992 0 | 154,992 | Form 3 |
| 9 | Bond Colin Michael Director | 2026-03-18 16:01:44 | 151,407 0 | 151,407 | Form 3 |
| 10 | Verduyn-van Weegen Felice Isabel Director | 2026-03-18 16:01:35 | 32,700 0 | 32,700 | Form 3 |
| 11 | Hammer Ohad Director | 2026-03-18 16:01:42 | 27,921 0 | 27,921 | Form 3 |